OCM
MCRB icon

Orion Capital Management’s Seres Therapeutics MCRB Stock Holding History

Orion Capital Management’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-50
Closed -$774 – 477
2024
Q1 		$774 Hold
50
– – ﹤0.01% 487
2023
Q4 		$1.4K Hold
50
– – ﹤0.01% 477
2023
Q3 		$2.38K Buy
+50
New +$3.82K ﹤0.01% 446
2023
Q2 		– Sell
-50
Closed -$5.67K – 321
2023
Q1 		$5.67K Hold
50
– – ﹤0.01% 398
2022
Q4 		$5.6K Hold
50
– – ﹤0.01% 338
2022
Q3 		$6K Hold
50
– – ﹤0.01% 346
2022
Q2 		$3K Hold
50
– – ﹤0.01% 388
2022
Q1 		$7K Hold
50
– – ﹤0.01% 352
2021
Q4 		$8K Hold
50
– – ﹤0.01% 326
2021
Q3 		$7K Hold
50
– – ﹤0.01% 322
2021
Q2 		$24K Hold
50
– – 0.01% 217
2021
Q1 		$21K Hold
50
– – 0.01% 215
2020
Q4 		$25K Buy
+50
New +$29.3K 0.02% 196

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Orion Capital Management's MCRB Position: Q2 2024 in Review

Orion Capital Management sold out of Seres Therapeutics (MCRB) in Q2 2024, closing a stake of 50 shares — an estimated $774 sold.

Orion Capital Management first reported a position in MCRB in Q4 2020 and held it in 13 quarters. The position peaked at $25K in Q4 2020. 93 funds tracked by Wall St. Rank hold MCRB as of Q2 2024.

  • Orion Capital Management reported no remaining Seres Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Orion Capital Management sold 50 Seres Therapeutics shares in Q2 2024, an estimated $774.
  • Orion Capital Management first reported a position in Seres Therapeutics in Q4 2020 and held it in 13 quarters.
  • Orion Capital Management's Seres Therapeutics position peaked at $25K in Q4 2020.
  • 93 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2024.

Based on Orion Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.